Petrus de Vries is founding director of the Centre for Autism Research in Africa (CARA) at the University of Cape Town in South Africa, and current president of the International Society for Autism Research.
Petrus de Vries
Founding director
Centre for Autism Research in Africa, University of Cape Town
From this contributor
Autism research is becoming more diverse but not yet more global
Hosting the International Society for Autism Research annual meeting—which starts tomorrow—in Australia takes a step in that direction, making it easier for researchers, clinicians and advocates from the Western Pacific Region to participate.
Autism research is becoming more diverse but not yet more global
What kind of autism research should we do, and where should we do it?
Researchers at INSAR 2023 need to discuss these questions and remember that the purpose of research may be different for different communities.
What kind of autism research should we do, and where should we do it?
How to offer support for young autistic children in South Africa
Coaching caregivers in early-intervention strategies may be the most effective way to help young autistic children in South Africa.
How to offer support for young autistic children in South Africa
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.